Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.

  • SOPHiA GENETICS's Cash from Investing Activities fell 8734.55% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year decrease of 7144.85%. This contributed to the annual value of -$8.2 million for FY2024, which is 19826.92% down from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Cash from Investing Activities is -$2.6 million, which was down 8734.55% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Cash from Investing Activities registered a high of $18.0 million during Q2 2022, and its lowest value of -$52.7 million during Q3 2021.
  • Its 5-year average for Cash from Investing Activities is -$1.1 million, with a median of -$1.3 million in 2021.
  • In the last 5 years, SOPHiA GENETICS's Cash from Investing Activities tumbled by 723857.94% in 2021 and then skyrocketed by 104409.53% in 2022.
  • Over the past 5 years, SOPHiA GENETICS's Cash from Investing Activities (Quarter) stood at -$1.3 million in 2021, then surged by 1043.12% to $12.1 million in 2022, then tumbled by 118.53% to -$2.2 million in 2023, then plummeted by 108.14% to -$4.7 million in 2024, then skyrocketed by 44.97% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$1.6 million for Q2 2025, and -$1.0 million during Q1 2025.